The adequacy of blood volume maintenance has been compared in two groups of patients undergoing planned surgery. One group received only stored blood; in the other group the first litre of replacement was with Macrodex. Blood volumes were measured immediately after induction of anaesthesia, immediately postoperatively, and 2-3 days postoperatively. The measured postoperative volumes were compared with the volume expected on the basis of the pre-operative measurement and the volumes of loss and replacement. No significant difference was detectable between the two groups with regard to the efficiency of volume replacement.
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A large amount of the blood supplied by the National Blood Transfusion Service is transfused into patients undergoing planned surgery, to maintain both circulating blood volume and oxygen carrying capacity. These functions are, of course, independent, and the physiological response to a deficit in either of them differs significantly. Deficit of circulating volume induces changes such as adrenergic hyperactivity, fall in cardiac output and diminution of flow to many tissues, which ultimately jeopardize the survival of the organism as a whole. Oxygen carrying capacity on the other hand is only one of the factors which influence the oxygen available to the tissues, and a considerable fall in haemoglobin concentration can be compensated for, provided the intravascular volume is maintained.
The reserve capacity for deficits in volume and haemoglobin are thus very different in patients who come to operation with a normal haemoglobin level and a normal cardiovascular system. Because of the greater physiological dangers of a volume deficit, anaesthetists use blood with volume replacement mainly in mind, and when the possibility of further loss exists, take care not to allow the margin of safety to become too narrow. If further losses do not, in fact, take place, the initial transfusion does not appear to here have been justified, when the matter is viewed retrospectively. Nevertheless, criticism of single unit volume replacement in these circumstances is illogical (Wiener, 1968) . However, it is not so illogical to condemn the use of whole blood for such a single unit transfusion since the implied aim is to prevent a significant fall in volume and to regard the accompanying reduction in haemoglobin as insignificant. Blood is a scarce and expensive commodity; it needs special storage and to be specially matched. Reactions and hepatitis are both potential complications. Volume replacement can be achieved with dextran of mean molecular weight (m.m.w.) of 70,000 (Macrodex, Pharmacia Ltd.) and this is relatively cheap. Macrodex can be stored anywhere and needs no special matching. This preparation appears to be free of many of the disadvantages of both dextran BP (m.m.w. 110,000) and of Rheomacrodex (m.m.w. 40,000). Unlike die former it need not interfere with subsequent cross-matching, does not induce pathological bleeding, allergic reactions or "sludging" of red M. D. VICKERS,* M.R.C.S., L.RX.P., M.B., B.S.(LOND.)> cells in micro-circulation. Unlike the latter it is only slightly hyperoncotic, remains in the circulation for a useful time, and is not excreted in quantities that might aggravate renal damage.
On theoretical grounds, therefore, there are reasons for thinking that the replacement of the initial 500 ml, or even 1000 ml of blood loss by Macrodex in non-anaemic patients would be physiologically acceptable in the short-term, and financially and practically desirable. Other factors operating over the long-term would need to be considered before such therapy could be uncritically recommended, however. Some have been the subject of clinical study already. Koekenberg (1962) in a controlled series found five times as many cases of postoperative phlebothrombosis and thromboembolism in patients receiving only stored blood, as in patients receiving Macrodex initially, and a comparable effect was observed by Stadil (1967) . Zederfeldt (1957) was unable to find any evidence that anaemia influenced wound healing, providing that plasma volume was maintained. Further matters which deserve study are any potential effects of acute anaemia on haemoglobin regeneration rates. Before investigating these it seems reasonable to be sure at least that the blood volume is maintained for a reasonable time as efficiendy by Macrodex as by stored blood, in routine surgical patients. This has been demonstrated over relatively short periods experimentally in bled volunteers (Gelin, Sewell and Zederfeldt, 1961) and in subjects in shock (Carey et al., 1965) . As a part of a study of the effects of Macrodex therapy, the maintenance of the total blood volume up to the second or third postoperative day was determined in patients who had eidier only stored blood or part Macrodex as replacement for operative blood loss.
MATERIALS AND METHODS
Twenty-two adult patients undergoing major surgery were studied. They were selected on the grounds that their blood loss might be expected to exceed 1 1. and that their pre-operative haemoglobin exceeded 12 g/100 ml. They were allocated randomly to two groups. In the first group blood loss was replaced with cross-matched blood as supplied by the National Blood Transfusion Service. In the second group blood loss was replaced with Macrodex up to a volume of 1 1.
Any replacement greater than this was with blood. Blood loss was estimated by the anaesthetist on the basis of swab weighing and measurement of suction loss. The anaesthetic technique consisted of barbiturate induction, intubation following suxamedionium and maintenance with nitrous oxide and oxygen, tubocurarine, with or without minimal halothane, or intravenous analgesics. Residual curarization was reversed with neostigmine preceded by atropine. Hartmann's solution was usually administered at the rate of approximately 500 ml/hr. Using a previously described technique (Heath, Vickers and Dunlap, 1969a ) red cell volume, plasma volume and peripheral haematocrit were determined, (1) immediately after induction of anaesthesia, (2) immediately after recovery of consciousness and (3) two or three days postoperatively. In seven of the patients only plasma volume and peripheral haematocrit were measured. Total blood volume and red cell volume were calculated for these cases using a whole body/large vessel haematocrit ratio appropriate to each group and time of measurement. The measurements from which these data were derived are detailed elsewhere (Heath, Vickers and Dunlap, 1969b) . The expected volume balance of the patients at the end of surgery was calculated from the anaesthetist's estimate of die blood loss and the volume of blood and/or Macrodex infused. No allowance was made for the anticoagulant in the stored blood, because the anaesthetists had not been specifically asked to do so.
RESULTS AND DISCUSSION
Four patients received no volume replacement because their blood loss was less than initially expected; data were incomplete on two other patients, and die results from diese six patients have been omitted. Detailed results from sixteen completed studies are presented in table I. Of these, seven received blood only and nine received Macrodex.
There was no significant difference in the estimated blood loss between die two groups (mean difference 204 ml; P=0.8). However, the anaesdietists apparently showed some bias in management. The expected volume balance at the end of operation was +250 ml (±218 ml) for patients receiving blood, and -45 ml (±284 ml) for patients receiving Macrodex. The difference (295 ml) is significant (P = 0.04). However, the actual volume balance, as represented by the difference between the pre-and postoperative blood volume measurements, although showing the same trend, was not significantly different between the two groups (difference, 276 ml; P = 0.2). A possible explanation for this trend is the tendency to give the whole bottle of blood once it has been started, whilst there is a greater willingness to discard part of a botde of Macrodex when the estimated colloid requirements have been met. To establish comparability in die management of the two groups, however, it is best to look at the discrepancy between die estimated blood volume at the end of operation (based on initial blood volume, estimated loss, and known replacement) and die actual blood volume at that time. These were very similar in bodi groups; mean discrepancy -185 ml (±397 ml) in die Macrodex group, and -204 ml (±422 ml) in the blood group. The mean difference of 18 ml between die groups is not significant (P = 0.9). It is thus fair to say diat bodi groups were equally well (or equally badly) managed in the practical terms of how nearly the estimated volume approached die true volume. It should be emphasized diat diis did not depend on a knowledge of the initial blood volume. The figures also reveal the common tendency towards undertxansfusion even though die subject is under study. When all die patients are taken togedier, diere is a deficit between die expected blood balance and die actual measured difference between die first and second blood volume measurements which is nearly significant (mean difference -193 ml; P = 0.07). This may indicate the order of inaccuracy of die blood loss Five patients received 2 litres in 24 hours of low molecular weight dextran (Rheomacrodex) during the first few postoperative days as part of their surgical management. These patients (indicated by asterisk in table I) showed a significant increase in their .blood volume compared with pre-operative value (mean difference +707 ml; P=0.04) and have been omitted from consideration of the 2-3 day postoperative study. The remaining patients showed no significant difference between the first and third measurements (mean difference-10 ml; P = 0.9) and there was no significant difference between the patients in whom loss was replaced with blood and those whose replacement included Macrodex (means: blood +227 ml; Macrodex -99ml;P=0.3).
CONCLUSIONS
Viewed solely from the standpoint of volume replacement, no significant difference could be detected between the patients who received Macrodex as part or all of the replacement for operative blood loss and those who received solely bank blood. This applied both immediately postoperatively and at the third measurement performed 2 or 3 days later when patients were once more in a stable state. 
